Case Report: Drug-induced liver injury mimicking hypereosinophilic syndrome

Yapalı S. , Yucel S., Sariguzel N., Saruc M. , Unal H. U. , Tıftıkcı A., ...More

AASLD-TASL Connect Meeting , İstanbul, Turkey, 15 - 16 March 2019, pp.34

  • Publication Type: Conference Paper / Summary Text
  • City: İstanbul
  • Country: Turkey
  • Page Numbers: pp.34


Case: A 56 year-old male presented with cough starting 3 months ago and jaundice and fatigue for one week. Labs showed ALT: 1994 IU/mL, AST: 1331 IU/mL, ALP: 221 U/L, GGT: 182 U/L, Total bilirubin: 10.1 mg/dL, Direct Bilirubin: 7.4 mg/dL, Prothrombin Time/INR: 31.8 sec/2.38, WBC: 28.900/mm3 and Eosinophil count: 14,450. ESR: 68/hr. He had a travel history to Phuket, New York Israel and Germany in the past 3 months, and reported walking in the sewage with open toe slippers at Phuket. Normal physical exam except for jaundice. Thorax CT done a week ago revealed 1.5 cm nodular lesion and ≈1 cm mediastinal LAP and FDG uptake of the lung nodule, spleen and bone marrow on the PET scan. He consumed 10 boxes of bronchomax syrup (Glycyrrhiza glabra, Ocimum Sanctum, Curcuma longa, Alpinia galangal, Piper longum, Mentha piperita, Zingiber oficinale, Greep Seed, White turmeric, Piper Nigrum extracts), Umca syrup (pelargonium sidoides), vardenaphile, glucasamine, milk thistle and 250 mg of powder curcumin to stop his cough in the past 3 months. The presentation with acute hepatitis, leukocytosis, eosinophilia, high ESR and high FDG uptake on the PET scan prompted the differential diagnosis of acute viral hepatitis, autoimmune hepatitis, parasitic infection, hypereosinophilic syndrome, myeloproliferative Diseases/Lymphoma, sarcoidosis, solid malignancy and drug-induced liver injury. Serology for viral hepatitis including HAV, HBC, HCV (and HCV RNA), HIV, HEV, EBV, CMV and HSV was negative. Protein electrophoresis and autoantibodies were negative. Abdominal imaging was normal. IgE: 435 (N<158) IU/mL, ACE:122 (N<52)IU/L. Infectious disease work-up for Echinococucus Ab (IHA), E. Histolytica, Stool parasite exam (x3), Salmonella Aggl (Gruber widal), Giardia Ag, C. Difficile toxin A and B, Shigella spp, Campylobacter group, Yersinia enterocolitica, Leishmania spp Ab, Ascaris lumbricoides, Schistosoma Ab:<1/80, Brucella Agg (Wright), Leptospira Ab, Fasciola hepatica Ab, Norovirus. Rotavirus, Dengue virus Ab were negative. During follow-up liver function tests (LFTs) and bilirubin levels started to decrease but eosinophilia persisted (Table 1). Liver biopsy showed acute hepatitis with centrilobular and bridging necrosis, central vein endothelitis (Figure 1). Hematology work-up to rule out hypereosinophilic syndrome, lymphoma and eosinophilic leukemia included peripheral blood smear, confirming hypereosinophilia, FIP1L/PDFGR was negative, and bone marrow biopsy findings of hypercellular bone marrow with increased eosinophils and erythroid cells. Pulmonology didn’t recommend work-up for sarcoidosis. LFTs started to decrease but as the eosinophilia persisted methyl prednisolone is started to protect from the potential risks for eosinophilia.  LFTs and bilirubin levels normalized in 2 weeks, steroid treatment was tapered and stopped in 1 month, ACE normalized and no pathological lymph nodes were detected in the repeat Thorax CT scan.

Discussion: This is an interesting case report of DILI presenting with hepatocellular injury and hypereosinophilia. The liver injury was probably due to an idiosyncratic hypersensitivity reaction by the combination of over-the-counter medications, which also triggered an antigenic stimulation of bone marrow resulting hypereosinophilia.